Operating Margin - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

Operating Margin
GlaxoSmithKline PLC

24.2%
Current
25%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.2%
=
Operating Profit
7.6B
/
Revenue
31.4B

Operating Margin Across Competitors

Country UK
Market Cap 79.2B USD
Operating Margin
24%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 843.2B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.4T DKK
Operating Margin
45%
Country US
Market Cap 385.8B USD
Operating Margin
29%
Country US
Market Cap 278.3B USD
Operating Margin
29%
Country CH
Market Cap 206.1B CHF
Operating Margin
32%
Country UK
Market Cap 240.2B USD
Operating Margin
21%
Country CH
Market Cap 191.2B CHF
Operating Margin
29%
Country US
Market Cap 162B USD
Operating Margin
19%

Profitability Report

View the profitability report to see the full profitability analysis for GlaxoSmithKline PLC.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.2%
=
Operating Profit
7.6B
/
Revenue
31.4B
What is the Operating Margin of GlaxoSmithKline PLC?

Based on GlaxoSmithKline PLC's most recent financial statements, the company has Operating Margin of 24.2%.